首页> 外国专利> Compound N - (4 - amidino - 2.6 - difluorobenzil) - 1 - (2 - (3 - Chloro - 5 - (Difluoromethoxy) phenyl) - 2 - hidroxiacetil). - 2 - carboxamide derivative and Pharmaceutical composition comprising the same, and its use in preparation of Medicine and Synthetic routes for its production

Compound N - (4 - amidino - 2.6 - difluorobenzil) - 1 - (2 - (3 - Chloro - 5 - (Difluoromethoxy) phenyl) - 2 - hidroxiacetil). - 2 - carboxamide derivative and Pharmaceutical composition comprising the same, and its use in preparation of Medicine and Synthetic routes for its production

机译:化合物N-(4--基-2.6-二氟苯甲酰基)-1-(2-(3-氯-5-(二氟甲氧基)苯基)2-盐酸羟乙乙胺)。 -2-羧酰胺衍生物和包含其的药物组合物,及其在制备药物和合成途径中的用途

摘要

A compound N - (4 - amidino - 2.6 - difluorobenzil) - 1 - (2 - (3 - Chloro - 5 - (Difluoromethoxy) phenyl) - 2 - hidroxialcetil). - 2 - carboxamide which responds to the formula (1) or a derivative thereof, including acceptable for pharmaceutical use of prodrugs the formula (1) wherein R1 represents OR2 or C (OR) OR3, R2 is H, alkyl, C1 - 10Alkylaryl C1 - 3 or alquiloxiarilo c1-3 alkyl (parties whose last two groups are optionally interrupted by one or more Oxygen ATOMS, and the parties whose last two aryl groups are optionally substituted by one or more substituents selected from Halogen, phenyl Methyl or methoxy,,The last three groups are optionally substituted by one or more substituents); R3 represents alkyl and Halogen C1 - 10 (whose last groups are optionally interrupted by one or more Oxygen Atoms), or alkylaryl C1 - 3 or alquiloxiarilo c1-3 alkyl cuy (Parties I last two groups are optionally interrupted by one or more Oxygen Atoms.And the parties whose last two aryl groups are optionally substituted by one or more substituents selected from Halogen, phenyl methyl or methoxy groups, of which the last three are also optionally substituted by one or more substituents) or an acceptable Pair Halogen derivative Pharmaceutical Use of the same.It also describes the pharmaceutical composition that comprises and the use of said compound in the manufacture of medicines.Such compounds and their Derivatives are useful as competitive inhibitors of Trypsin like proteases, such as thrombin, or are useful as prodrugs of and therefore are particularly useful for the treatment of conditions which require the inhibition of Thrombin ( For example, thrombosis) or as anticoagulants.
机译:化合物N-(4--基-2.6-二氟苯甲腈)-1-(2-(3-氯-5-(二氟甲氧基)苯基)2-羟乙基纤维素)。 -对式(1)或其衍生物具有响应的羧酰胺,包括可药用的式(1)的前药,其中R1代表OR2或C(OR)OR3,R2为H,烷基,C1-10烷基芳基C1 -3或alquiloxiarilo c1-3烷基(其后两个基团可选地被一个或多个氧原子ATOMS中断的主体,以及其后两个芳基基团被一个或多个选自卤素,苯基甲基或甲氧基的取代基取代的主体,最后三个基团任选被一个或多个取代基取代; R 3代表烷基和卤素C1-10(其最后一个基团可选地被一个或多个氧原子打断),或烷基芳基C1-3或Alquiloxiarilo c1-3烷基cuy(第I部分的后两个基团可选地被一个或多个氧原子打断)并且最后两个芳基被一个或多个选自卤素,苯基甲基或甲氧基的取代基取代的一方,其中最后三个芳基也被一个或多个取代基取代)或可接受的成对卤素衍生物还描述了包含所述化合物的药物组合物及其在药物生产中的用途。此类化合物及其衍生物可用作胰蛋白酶如蛋白酶的竞争性抑制剂,例如凝血酶,或用作和/或前药。因此,其对于需要抑制凝血酶(例如血栓形成)或作为抗凝剂的疾病的治疗特别有用。

著录项

  • 公开/公告号AR037498A1

    专利类型

  • 公开/公告日2004-11-17

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号AR2002P103296

  • 申请日2002-08-30

  • 分类号C07D405/04;A61K31/397;A61P7/02;C07D401/12;C07D203/04;C07D213/02;C07D403/12;C07D205/04;C07D204/02;C07D413/12;C07D203/02;C07D261/02;C07D417/12;C07D231/02;C07D233/02;C07D405/12;C07D307/78;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:53

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号